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CORRESPONDENCE
Letters to the Editor
Relationship Between
Noninvasive Coronary
Angiography With Multislice
Computerized Tomography and
Myocardial Perfusion Imaging
In the paper by Schuijf et al. (1), they report findings on
myocardial perfusion imaging (MPI) and multislice computer-
ized tomography (MSCT) in symptomatic patients referred for
MPI. Although the findings were of great interest, we were
concerned with several of the conclusions the authors drew from
them. In a subset of the patients reported (58 of 114) invasive
coronary angiography was performed. Of the 27 patients
demonstrated to have angiographically severe coronary stenosis,
MSCT identified 27 (100%) and MPI identified only 16 (59%).
Of the 31 patients shown not to have severe coronary stenosis,
MSCT identified 25 (82%) and MPI identified 15 (48%). From
these results, the investigators’ conclusion was that “the dis-
crepant results provided by the 2 techniques underscore that
MSCT and MPI provide complementary information.” This
conclusion is surprising, because although the authors offer
reasonable evidence that the 2 techniques yield discrepant
results, they give no evidence that the techniques are comple-
mentary. Because the authors do not offer any prestated
hypothesis, their conclusion seems to be imposed on post hoc
data that showed surprisingly poor efficacy for the current
reference standard noninvasive examination, MPI. Although
other studies have shown a relatively low clinical event rate in
patients with normal MPI exams, it is not known if a benign
prognosis can be generalized to symptomatic patients with
severe coronary artery disease (CAD) demonstrated on angiog-
raphy (2–4).
The authors also state that “patients with an abnormal MSCT
and abnormal MPI should be referred for invasive angiography
with potential revascularization.” This conclusion, too, is not based
on their presented data. The decision to pursue invasive testing is
complex and generally based on the patient’s clinical features. It is
therefore an overly broad conclusion to base this decision solely on
the suggestion of abnormal perfusion seen on MPI. Sequential
testing, which the authors advocate, seems a costly and unnecessary
step.
The accuracy with which MSCT demonstrates the presence and
extent of CAD makes it a welcome addition to the noninvasive
armamentarium. Based on the authors’ findings of frequent dis-
crepant results between these techniques, further investigation is
warranted to test patient outcomes when clinical decisions are
guided by MSCT versus MPI.
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Reply
We thank Drs. Spevack and Levsky for their interest in our article
on the relationship between multislice computed tomography
(MSCT) coronary angiography and myocardial perfusion imaging
(MPI) (1).
In our study, MSCT and MPI were compared in patients with
an intermediate pretest likelihood. In the majority of patients with
normal MSCT (no atherosclerosis), MPI was normal as well.
However, in patients with significant lesions on MSCT, MPI
results were abnormal in only 50%, indicating that MSCT can not
predict abnormal perfusion/ischemia. Nonetheless, these observa-
tions also showed that the presence of substantial atherosclerosis,
including significant stenoses, cannot be ruled out by MPI. Thus,
the techniques may be considered to provide different information;
whereas MPI provides information on the presence of ischemia,
MSCT tells us whether atherosclerosis is present or not. Integra-
tion of both, therefore, may prove helpful in deciding the optimal
treatment strategy.
The first concern that Drs. Spevack and Levsky raise is that our
observations appear to be based on data showing poor efficacy for
MPI. However, their argument is predominantly based on the
findings of a subanalysis of our data, namely, the performance of
MSCT and MPI in those patients referred for conventional
coronary angiography. However, we recommend that those obser-
vations be treated with care, because they are hampered by the
presence of referral bias, thus negatively influencing MPI results in
particular. In our paper, therefore, those data are solely used to
confirm that MSCT has a good diagnostic accuracy in patients at
intermediate risk. Moreover, one needs to realize carefully that
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